Sponsored by Ionis Pharmaceuticals, the FCS Genetic Testing program from Prevention Genetics is available to certain qualifying patients who have:
- Extremely high triglyceride levels (> 880 mg/dL or > 10 mmol/L) on two fasting blood tests in a row.
- No other known causes of high TG levels.
As part of the program’s partnership, an independent genetic counseling service, Genome Medical, can provide information on FCS and support during the genetic testing process
Call +1 888.478.1494 to learn more.
Arrowhead Pharmaceuticals is partnering with Ambry Genetics to provide a sponsored genetic testing program for patients who have a clinical history of severe hypertriglyceridemia. Patients who are eligible for this program may have an underlying genetic cause of their complications, such as Familial Chylomicronemia Syndrome or hyperlipoproteinemia. This test can only be ordered by a health care provider.
Program Eligibility
- 17 years of age and older AND
- Fasting triglyceride level of > 600 mg/dL [> 6.77 mmol/L] in the past 12 months
For patients and families, genetic testing can lead to an accurate and early diagnosis of FCS, familial hypertriglyceridemia, or hyperlipoproteinemia. Arrowhead Pharmaceuticals is sponsoring genetic testing through Ambry Genetics to help facilitate early diagnosis, which can help optimize disease management.
Visit Identify Genetic Etiologies in Patients w/ Severe Hypertriglyceridemia to learn more.